Back to discover
Drug

Tetracycline

In clinical development
ClassBacterial 70S ribosome inhibitorEmerging researchLate-stage development
Also known as Ala-Tet, Brodspec, Emtet-500, Pylera+17 more

Ala-Tet, Brodspec, Emtet-500, Pylera, Robitet 500, Tetra 500, Tetracap, Tetracon, Tetrazyklin, Tsiklomitsin, Viabecline, Vitastem, Achromycin, Panmycin, Sumycin, Topicycline, Tetracyclin, Tétracycline, (4S,4aS,5aS,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide, Tetracycline Hydrochloride, Tetracyclinum.

1
Research papers
3
Active clinical trials
55
Protein targets
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Helicobacter Pylori Eradication and Follow-up in Zhongshan Hospital

Clinical trial2026-06-30Primary completion · ClinicalTrials.gov

Sanitation, Water, and Instruction in Face-washing for Trachoma I/II

Clinical trial2024-12-31Completed · ClinicalTrials.gov

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Tetracycline
Aliases & brands
Ala-TetBrodspecEmtet-500PyleraRobitet 500Tetra 500TetracapTetraconTetrazyklinTsiklomitsinViabeclineVitastemAchromycinPanmycinSumycinTopicyclineTetracyclinTétracycline(4S,4aS,5aS,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamideTetracycline HydrochlorideTetracyclinum
RxNorm CUI
10395
ChEMBL ID
CHEMBL1440
ATC codes
D06AA04S03AA02S01AA09S02AA08A01AB13J01AA07
UNII
F8VB5M810T
Primary mechanism
Bacterial 70S ribosome inhibitor

Pharmacology & targets

55 targets

Known molecular targets and mechanisms supported by curated pharmacology databases.

INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor
INHIBITORBacterial 70S ribosome inhibitor

Clinical trials

39 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
39
registered trials across all phases
LATEST COMPLETION 2026
3
Active studies
3
Recruiting
31
Late-stage (III+)
22
Completed
14
Discontinued
PHASE DISTRIBUTIONn = 39
Early Phase 12Phase 11Phase 25Phase 2 / 31Phase 32Phase 423Phase N / A5

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Recent completions

Trials that read out recently, adding to the completed evidence base.

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Journals, researchers & institutions
Top journals
  • The Journal of clinical investigation1
Leading researchers
  • Benjamin LE1
  • Golijanin D1
  • Itin A1
  • Keshet E1
  • Pode D1
Leading institutions
free-text, unnormalised
  • The Hebrew University/Hadassah Medical School1

Related drugs

1 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Studied across 3 of the same disease areas as Tetracycline in the shared literature.

3 shared diseases1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials